The expression level of Nanog in LSCs was analyzed in CD34+ cells isolated from blood samples of patients with AML (Supplementary Table S2) using MACS according to our previous study (Zhang et al., 2015) and in CD34+CD38- LSCs isolated from AML cell lines KG-1a and MOLM13. This evidence concerns the gene NANOG and acute myeloid leukemia.